Duquesne University: New Study Highlights Differences in Neuropathic Pain Relief for Men and Women
June 22, 2022
June 22, 2022
PITTSBURGH, Pennsylvania, June 22 (TNSjou) -- Duquesne University issued the following news release:
A new Duquesne University study using a nanomedicine that targets neuropathic pain at its source found that while males and females develop pain-like behavior to the same degree, the nanomedicine provided less relief for females.
The study, published in Scientific Reports (Nature), tested male and female rats using a nonsteroidal anti-inflammatory drug (NSAID) nanoemulsi . . .
A new Duquesne University study using a nanomedicine that targets neuropathic pain at its source found that while males and females develop pain-like behavior to the same degree, the nanomedicine provided less relief for females.
The study, published in Scientific Reports (Nature), tested male and female rats using a nonsteroidal anti-inflammatory drug (NSAID) nanoemulsi . . .